Sorted By:

Relevance


ICYMI: New Study Underscores Access Challenges in Essential Health Benefit Plans

PhRMA  |  Blog Post

” Consumers need easy-to-understand, readily available resources to help them compare costs and the coverage of medicines so they can choose the plan that works best for them and their family.
http://catalyst.phrma.org/icymi-new-study-shows-underscores-access-challenges-in-essential-health-benefit-plans

About Access Better Coverage

Access Better Coverage  |  From PhRMA

The site also serves as a resource for comprehensive reports and fact sheets on coverage of prescription medicines.
http://www.accessbettercoverage.org/about-access-better-coverage

EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing

PhRMA  |  Blog Post

The workshop will seek to propose guiding principles to enable international data sharing – an area in which PhRMA and its member companies are leading the way.  
http://catalyst.phrma.org/efpia-phrma-principles-successfully-enable-responsible-clinical-trial-data-sharing

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

PhRMA  |  Blog Post

And therefore the quality of life is even better, if not even in fact an extension of life has been achieved.”
http://catalyst.phrma.org/icymi-the-new-era-of-medicine-initiative-spotlights-genomics-in-nyc

Advancing the science for patients with rare diseases

PhRMA  |  Blog Post

2015 was a banner year for advances in rare disease treatments: 47 percent of new drug approvals were for rare diseases (A noteworthy uptick over the average of just over 35 percent in the last five years) 8 first-in-class treatments, representing entirely new ways for treating disease 11 new cancer therapies 5 new medicines for pediatric patients New treatments for cystic fibrosis, difficult-to-treat high cholesterol and several enzyme deficiency disorders The fact sheet explores 2015 treatment advances in rare diseases, including new therapeutic options for patients with multiple myeloma and cystic fibrosis, as well as new treatments for several rare diseases affecting pediatric patients.
http://catalyst.phrma.org/advancing-the-science-for-patients-with-rare-diseases

Week in review: The latest from PhRMA

PhRMA  |  Blog Post

fact sheets from RxEconomics, LLC, in collaboration with PhRMA, highlight the economic burden of treating Medicaid recipients with hepatitis C and the opportunity for newer and more effective medicines to lower health care costs with greater efficacy.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-january-8-2016

Local Impact: Hepatitis C and Medicaid spending

PhRMA  |  Blog Post

The fact sheets further underscore the importance of acknowledging the value that innovative treatments provide in managing long-term health care spending.
http://catalyst.phrma.org/local-impact-hepatitis-c-and-medicaid-spending

Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

In fact, the American Journal of Preventive Medicine found that an estimated 70 million people in the United States live with hypertension, while only half have the condition under control.
http://catalyst.phrma.org/celebrating-hope-for-patients-and-families-on-world-heart-day-2016

How biopharmaceutical collaboration is driving a new era of medicine

PhRMA  |  Blog Post

new research illustrates there has been a significant shift in recent years from traditional, asset-based or transactional agreements to more open, collaborative approaches for conducting biopharmaceutical research.
http://catalyst.phrma.org/collaboration-driving-new-era-of-medicine

Burden on Patients: 5 Questions on access to rheumatoid arthritis medicines in health exchange plans

PhRMA  |  Blog Post

Learn more on AccessBetterCoverage.org, in our patient profiles and our other fact sheets.
http://catalyst.phrma.org/burden-on-patients-5-questions-on-access-to-rheumatoid-arthritis-medicines-in-health-exchange-plans

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Medicare Monday: Check out this week’s post, which busts a popular myth about negotiation in Medicare Part D, explaining how powerful Part D purchasers negotiate discounts and rebates directly with manufacturers that save money for both beneficiaries and taxpayers.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-august-21-2015

Ed Y.

From Hope To Cures  |  From Our Network

I have permanent nerve damage in my feet.
http://www.fromhopetocures.org/imnotaverage/ed-y

Helping those affected by the 2017 hurricane season

PhRMA  |  Blog Post

announced that a comprehensive disaster relief effort has been implemented, including the following activities: (1) the Pfizer Foundation has made significant cash grants to key organizations leading relief efforts on the ground, including the American Red Cross, World Vision, and Americares. (2) The Pfizer Foundation has implemented a special one-to-one to match for cash donations made by Pfizer colleagues to the American Red Cross for the relief efforts during the next month. (3) Donations of Pfizer prescription and consumer products are currently underway through Direct Relief and Americares, and Pfizer is prepared to make additional product donations to these organizations and others as needed. (4) Disaster protocols for its patient assistance programs in the affected areas have been activated:  waiving financial documentation requirements for new patients; allowing existing patients to request refills earlier; and enabling hospitals and clinics that participate in its bulk replenishment program to request additional product to replace inventory lost in the storm and/or to meet increased demand.
http://catalyst.phrma.org/helping-those-affected-by-hurricane-harvey

PhRMA Brings Scientists to Capitol Hill

PhRMA  |  Press Release

(September 21, 2016) – Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) is bringing more than 60 researchers and scientists from its member companies to meet with members of Congress to discuss how they can help support development of new, innovative medicines for patients in need.
https://www.phrma.org/press-release/phrma-brings-scientists-to-capitol-hill

Burden on Patients: Prescription Management is Critical for Diabetes Patients

PhRMA  |  Blog Post

fact sheets.
http://catalyst.phrma.org/burden-on-patients-prescription-management-is-critical-for-diabetes-patients

Jacob B.

From Hope To Cures  |  From Our Network

Thanks to an incredible partnership between our hospital and Nike, Jacob is one of six patients out of hundreds of thousands that were given the opportunity to design a one-of-a-kind pair of shoes & apparel that will benefit the hospital that saves children’s lives on a daily basis.
http://www.fromhopetocures.org/imnotaverage/jacob-b

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Subsequently, a letter signed by 79 Members of Congress was sent to House leadership emphasizing how critical reform is for the full spectrum of industry.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-july-31-2015

New Report: Nearly 4.5 Million U.S. Jobs and $1.2 Trillion Economic Output Supported by Biopharmaceutical Sector in 2014

PhRMA  |  Press Release

A U.S. fact sheet and fact sheets for all 50 states plus the District of Columbia are available online, as is the full report with detailed findings and methodology.
https://www.phrma.org/press-release/new-report-nearly-4-5-million-u-s-jobs-and-1-2-trillion-economic-output-supported-by-biopharmaceutical-sector-in-2014

What they are saying: Immunotherapy is transforming cancer care

PhRMA  |  Blog Post

#immunotherapy pic.twitter.com/GOevB2JAG7 — Cleveland Clinic MD (@CleClinicMD) April 10, 2016 The promise of .com/hashtag/immunotherapy?
http://catalyst.phrma.org/what-they-are-saying-immunotherapy-is-transforming-cancer-care

Burden on Patients: 5 Questions on Access to Diabetes Medicines in Health Exchange Plans

PhRMA  |  Blog Post

When the possible complications seem far down the road and you don’t feel anything immediately, you really have to make sure you are working closely with your doctor to control the disease because uncontrolled diabetes is not something that anyone wants to deal with.
http://catalyst.phrma.org/burden-on-patients-5-questions-on-access-to-diabetes-medicines-in-health-exchange-plans

Industry Economic Impact

PhRMA  |  From PhRMA

A U.S. fact sheet and fact sheets for all 50 states plus the District of Columbia are available below, as is the full report with detailed findings and methodology. 
https://www.phrma.org/media/industry-economic-impact

PhRMA launches biologics and biosimilars online resources

PhRMA  |  Blog Post

Additionally, a number of downloadable fact sheets and infographics are available on more in-depth biologics and biosimilars topics.
http://catalyst.phrma.org/phrma-launches-biologics-and-biosimilars-online-resources

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Must-know facts include: Treating people with one or more chronic condition consumes 90 cents of every dollar spent on health care.
http://catalyst.phrma.org/new-data-put-medicine-costs-and-spending-in-context

I'm Not Average: Jamie Survives Cancer Despite the Odds

PhRMA  |  Video

In this video, Jamie shares that CML is a disease she will always have, but because of these innovations, she’s happy and able to manage her disease.
https://www.phrma.org/video/i-m-not-average-jamie-survives-cancer-despite-the-odds

New Study: Substantial rebates negotiated in Medicare Part D

PhRMA  |  Blog Post

This new report confirms the significant negotiation occurring in Medicare.
http://catalyst.phrma.org/new-study-substantial-rebates-negotiated-in-medicare-part-d

You have reviewed the first 250 results out of 1198. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next